A detailed history of Navellier & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Navellier & Associates Inc holds 4,970 shares of BSX stock, worth $490,340. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,970
Previous 4,970 -0.0%
Holding current value
$490,340
Previous $382,000 8.9%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $14,400 - $17,155
250 Added 5.3%
4,970 $340,000
Q4 2023

Feb 08, 2024

BUY
$48.64 - $57.81 $229,580 - $272,863
4,720 New
4,720 $272,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.